Drug Description in Trials / DrugBank / KEGG DRUG /

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1111JC101----[1] 25
2Cidofovir[1] Cidofovir[1] D00273 --[1] 25
3Collection of blood and urine----[1] 25
4CYT107----[1] 25
5Cytarabine[1] Cytarabine[3] D00168 ,
D03046 ,
D03637 		--[7] 11, 13, 14, 25, 49, 60, 65
6Diagnostic Test: Brain MRI----[2] 25, 229
7Didanosine[1] Didanosine[1] D00296 --[2] 25, 265
8Emtricitabine[1] Emtricitabine[1] D01199 --[4] 25, 93, 265, 325
9Enfuvirtide[1] Enfuvirtide[1] D02499 --[2] 25, 265
10Filgrastim[1] Filgrastim[1] D03235 [1] CSF3R 💬[5] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬[28] 2, 6, 13, 25, 26, 28, 34, 35, 38, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 96, 113, 164, 256, 283, 284, 285, 296, 331
11Interferon alfa[1] Interferon alfa[1] D03305 [2] IFNAR1,
IFNAR2 💬		[18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[5] 25, 26, 28, 56, 96
12Interferon alfa-2b[2] Interferon alfa,
Interferon alfa-2b		[2] D02745 ,
D03305 		[2] IFNAR1,
IFNAR2 💬		[18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[1] 25
13Interleukin-7[1] Interleukin-7---[1] 25
14Lariam[1] Mefloquine[1] D04895 --[1] 25
15MEFLOQUINE[1] Mefloquine[1] D04895 --[2] 25, 46
16Methylprednisolone[1] Methylprednisolone[6] D00407 ,
D00751 ,
D00979 ,
D05000 ,
D05001 ,
D05002 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[48] 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 86, 93, 95, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296, 300
17NATALIZUMAB[1] Natalizumab[1] D06886 [1] ITGA4 💬[14] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬[5] 13, 15, 25, 46, 96
18Neurological evaluation----[1] 25
19NT-I7[1] Efineptakin alfa[1] D11957 --[1] 25
20Pembrolizumab[1] Pembrolizumab[1] D10574 [1] PDCD1 💬[3] Cell adhesion molecules, PD-L1 expression and PD-1 checkpoint pathway in cancer, T cell receptor signaling pathway 💬[2] 25, 285
21PREDNISOLONE[1] Prednisolone[8] D00472 ,
D00980 ,
D00981 ,
D00982 ,
D01239 ,
D01998 ,
D02156 ,
D03301 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[43] 3, 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 113, 145, 162, 222, 269, 271, 296, 299, 300, 307
22Probenecid[1] Probenecid[1] D00475 --[1] 25
23PyVST----[1] 25
24Recombinant human interleukin-7[1] Interleukin-7---[1] 25
25Spinal tap----[1] 25
26Tenofovir[1] Tenofovir disoproxil[1] D01982 --[6] 2, 13, 25, 93, 265, 325
27Tenofovir-Emtricitabine[2] Emtricitabine,
Tenofovir		[2] D01199 ,
D06074 		--[1] 25
28TERIFLUNOMIDE[1] Teriflunomide[1] D10172 [1] DHODH 💬[3] Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬[3] 13, 25, 26
29Topotecan[1] Topotecan[2] D02168 ,
D08618 		[1] TOP1 💬-[1] 25
30TYSABRI[1] Natalizumab[1] D06886 [1] ITGA4 💬[14] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬[3] 13, 25, 63
31Zalcitabine[1] Zalcitabine[1] D00412 --[1] 25
32Zidovudine[1] Zidovudine[1] D00413 --[6] 25, 26, 135, 265, 325, 331